LITH (BioELife) E10: $-0.14 (As of Sep. 2019)


What is BioELife E10?

BioELife LITH -99.00% E10 is $-0.14 as of Sep. 2019.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BioELife's adjusted earnings per share data for the three months ended in Sep. 2019 was $-0.010. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.14 for the trailing ten years ended in Sep. 2019.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-02), BioELife's current stock price is $1.0E-6. BioELife's E10 for the quarter that ended in Sep. 2019 was $-0.14. BioELife's Shiller PE Ratio of today is .


BioELife  (OTCPK:LITH) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BioELife E10 Related Terms


BioELife E10 Historical Data

* Premium members only.

The historical data trend for BioELife's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioELife E10 Chart

BioELife Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.28 -0.16 -0.16

BioELife Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 -0.16 -0.15 -0.15 -0.14

LITH vs BSPK, PCYN, CNABQ: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BioELife's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioELife Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioELife's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BioELife's Shiller PE Ratio falls into.



BioELife E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioELife's adjusted earnings per share data for the three months ended in Sep. 2019 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2019 (Change)*Current CPI (Sep. 2019)
=-0.01/256.7590*256.7590
=-0.010

Current CPI (Sep. 2019) = 256.7590.

BioELife Quarterly Data

per share eps CPI Adj_EPS
200912 0.000 215.949 0.000
201003 0.000 217.631 0.000
201006 0.000 217.965 0.000
201009 0.000 218.439 0.000
201012 0.000 219.179 0.000
201103 0.000 223.467 0.000
201106 0.000 225.722 0.000
201109 0.000 226.889 0.000
201112 0.000 225.672 0.000
201203 0.000 229.392 0.000
201206 0.000 229.478 0.000
201209 0.000 231.407 0.000
201212 0.000 229.601 0.000
201303 0.000 232.773 0.000
201306 0.000 233.504 0.000
201309 -0.001 234.149 -0.001
201312 0.042 233.049 0.046
201403 -0.400 236.293 -0.435
201406 0.000 238.343 0.000
201409 -0.018 238.031 -0.019
201412 0.000 234.812 0.000
201503 -0.024 236.119 -0.026
201506 -0.009 238.638 -0.010
201509 -0.007 237.945 -0.008
201512 -0.009 236.525 -0.010
201603 -0.011 238.132 -0.012
201606 -0.028 241.018 -0.030
201609 -0.025 241.428 -0.027
201612 -0.029 241.432 -0.031
201703 -0.026 243.801 -0.027
201706 -0.018 244.955 -0.019
201709 -0.020 246.819 -0.021
201712 -0.036 246.524 -0.037
201803 -0.020 249.554 -0.021
201806 0.070 251.989 0.071
201809 0.010 252.439 0.010
201812 -0.200 251.233 -0.204
201903 0.030 254.202 0.030
201906 -0.040 256.143 -0.040
201909 -0.010 256.759 -0.010

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.14 mean?
BioELife (LITH) has a E10 of $-0.14 as of Sep. 2019. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on BioELife and its competitors.
Is BioELife's E10 too high?
BioELife's current E10 is $-0.14.
How does BioELife's E10 compare to BSPK and PCYN?
BioELife's E10 of $-0.14 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on BioELife and its competitors. BioELife's current E10 is $-0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioELife stock overvalued right now?
BioELife (LITH) has a current E10 of $-0.14. The current E10 is $-0.14. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For BioELife (LITH), the current E10 is $-0.14 as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioELife Business Description

Address 12340 Seal Beach Boulevard, Suite B-190, Seal Beach, CA, USA, 90740
BioELife Corp is engaged in the manufacturing and distribution of Cannabinoid products. The company's product portfolio includes Combo Adult Gummies with Chirorub; Combo Tincture with Chirorub; Intensive Relief Rub; Tinctures; Adult Gummies; Premium Pre-Rolls; and Flower.